Par Drugs and Chemicals Limited — Board Meeting, 07-08-2025: Outcome of Board Meeting

PAR DRUGS AND CHEMICALS: The Board has announced a board meeting on Aug 7 where it approved the standalone financial results for the quarter ended June 30, 2025 (Q1 FY26). The company reported strong performance, with revenue from operations climbing to ₹26.05 Cr from ₹22.61 Cr in Q1 FY25. Profit for the period significantly increased to ₹3.33 Cr, up from ₹2.53 Cr last year. Additionally, the Board approved the renewal of its existing banking facility of ₹1.61 Cr with Kotak Mahindra Bank, maintaining the same limit.